Amifampridine
(Redirected from Firdapse)
What is Amifampridine?[edit | edit source]
Amifampridine (FIRDAPSE) is a potassium channel blocker used to treat Lambert-Eaton myasthenic syndrome (LEMS).
What are the uses of this medicine?[edit | edit source]
- This medicine is used to treat Lambert-Eaton myasthenic syndrome (LEMS) in adults.
How does this medicine work?[edit | edit source]
- The mechanism by which amifampridine exerts its therapeutic effect in LEMS patients has not been fully elucidated.
- Amifampridine is a broad spectrum potassium channel blocker.
Who Should Not Use this medicine ?[edit | edit source]
This medcine cannot be used in patients with:
- A history of seizures
- Hypersensitivity to amifampridine phosphate or another aminopyridine
What drug interactions can this medicine cause?[edit | edit source]
- The concomitant use of FIRDAPSE and drugs that lower seizure threshold may lead to an increased risk of seizures.
- The concomitant use of FIRDAPSE and drugs with cholinergic effects (e.g., direct or indirect cholinesterase inhibitors) may increase the cholinergic effects of FIRDAPSE.
Is this medicine FDA approved?[edit | edit source]
- It was approved for use in the United States in 2018.
How should this medicine be used?[edit | edit source]
Recommended Dosageː
- The recommended starting dosage of FIRDAPSE is 15 mg to 30 mg daily, taken orally in divided doses (3 to 4 times daily).
- The dosage can be increased by 5 mg daily every 3 or 4 days.
- The maximum recommended total daily dosage is 80 mg.
- The maximum single dose is 20 mg.
Patients with Renal Impairment:
- The recommended starting dosage of FIRDAPSE in patients with renal impairment (creatinine clearance 15 to 90 mL/min) is 15 mg daily, taken orally in 3 divided doses.
- No dosage recommendation for FIRDAPSE can be made for patients with end-stage renal disease.
Patients with Hepatic Impairment:
- The recommended starting dosage of FIRDAPSE in patients with any degree of hepatic impairment is 15 mg daily, taken orally in 3 divided doses.
Administration
- Take FIRDAPSE exactly as your doctor tells you to take it. Do not change your dose of FIRDAPSE.
- Do not take more than 2 tablets of FIRDAPSE at one time or more than 8 tablets in a 24-hour period.
- FIRDAPSE can be taken with or without food.
- If you miss a dose of FIRDAPSE, skip that dose and take your next dose at your next scheduled dose time. Do not double your dose to make up the missed dose.
- Do not take FIRDAPSE together with other medicines known to increase the risk of seizures.
- If you take too much FIRDAPSE, call your doctor or go to the nearest hospital emergency room right away.
What are the dosage forms and brand names of this medicine?[edit | edit source]
This medicine is available in fallowing doasage form:
- As Tablets: 10 mg, functionally scored
This medicine is available in fallowing brand namesː
- FIRDAPSE
What side effects can this medication cause?[edit | edit source]
The most common side effects of this medicine include:
- tingling around the mouth, tongue, face, fingers, toes, and other body parts
- upper respiratory infection
- stomach pain
- nausea
- diarrhea
- headache
- increased liver enzymes
- back pain
- high blood pressure
- muscle spasms
FIRDAPSE may cause serious side effects, including:
- Seizures
- Serious allergic reactions, such as anaphylaxis
What special precautions should I follow?[edit | edit source]
- FIRDAPSE can cause seizures. Consider discontinuation or dose-reduction of FIRDAPSE in patients who have a seizure while on treatment.
- In clinical trials, hypersensitivity reactions and anaphylaxis associated with FIRDAPSE administration have not been reported. If a hypersensitivity reaction such as anaphylaxis occurs, FIRDAPSE should be discontinued and appropriate therapy initiated.
What to do in case of emergency/overdose?[edit | edit source]
- Overdose with FIRDAPSE was not reported during clinical studies.
Management for overdosage:
- Patients with suspected overdose with FIRDAPSE should be monitored for signs or symptoms of exaggerated FIRDAPSE adverse reactions or effects, and appropriate symptomatic treatment instituted immediately.
Can this medicine be used in pregnancy?[edit | edit source]
- There are no data on the developmental risk associated with the use of FIRDAPSE in pregnant women.
- There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to FIRDAPSE during pregnancy. Physicians are encouraged to enroll pregnant patients, or pregnant women may register themselves in the registry by calling 855-212-5856 (toll-free), using the Fax number 877-867-1874 (toll-free), by contacting the Pregnancy Coordinating Center at firdapsepregnancyregistry@ubc.com
Can this medicine be used in children?[edit | edit source]
- Safety and effectiveness in pediatric patients have not been established.
What are the active and inactive ingredients in this medicine?[edit | edit source]
- Active ingredient: amifampridine
- Inactive ingredients: calcium stearate, colloidal silicon dioxide, and microcrystalline cellulose.
Distributed by Catalyst Pharmaceuticals, Inc., Coral Gables
Who manufactures and distributes this medicine?[edit | edit source]
- Packager: Catalyst Pharmaceuticals, Inc.
What should I know about storage and disposal of this medication?[edit | edit source]
- Store FIRDAPSE at 68°F to 77°F (20°C to 25°C).
- Safely throw away FIRDAPSE that is out of date or no longer needed.
- Keep FIRDAPSE and all medicines out of the reach of children.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju